Olema Pharmaceuticals Azioni (NASDAQ: OLMA)

Olema Pharmaceuticals

OLEMA PHARMACEUTICALS INC

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

MODV

OLMA

Le azioni sanitarie più promettenti da considerare per il quarto trimestre, con valutazioni attuali e proiezioni di crescita.

Le 3 azioni sanitarie da comprare ora: le migliori opportunità

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals inc

Press Releases

Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Earnings

Olema Oncology Reports Second Quarter 2025 Financial and Operating Results

Small Cap

Opinion

Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Olema Oncology to Participate in Upcoming Investor Conferences

Health Care

Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer

IOBT

ONCY

PDSB

PRPH

TSX:ONC

Absci

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

Akebia Therapeutics

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

CareDx

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Erasca

Gyre Therapeutics

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Inventiva S.A. - American Depository Shares

Inventiva

Kodiak Sciences

Keros Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

MeiraGTx Hldgs

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Monopar Therapeutics

Myriad Genetics

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Regenxbio

Rezolute

Tango Therapeutics

Tyra Biosciences

UroGen Pharma

Guggenheim

Oppenheimer

JP Morgan

Citigroup

Goldman Sachs

Comments

Olema Pharmaceuticals

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO